With knowledge of legal and regulatory affairs of medical devices, Bio-pharmaceuticals, cosmetics, and foods, MediHelpLine Corp. is in charge of licensing, production, and quality assurance and communicating with MFDS.
MediHelpLine Corp. has experiences in Phase I ~ III and Phase IV trials in almost all therapeutic areas. It supports at every stage such as study designing, clinical operation, data management, statistical analysis and medical writing.
For observational studies like Post Marketing Surveillance (PMS), Non-Interventional Studies (NIS), Post-Authorisation Safety Studies (PASS) or Post-NDA studies, MediHelpLine provides high-quality of comprehensive electronic data capture (EDC) system which meets the relevant regulatory requirements.
R&D Center not only strengthens the current portfolio but searches for new drug which can provide a new opportunity to potential patients. It also participates in the national research project on medical devices.